Home|2019|September

Prof. Daniel Palanker

Stanford University (USA)

Prof. Palanker is heading the Department of Ophthalmology and Hansen Experimental Physics laboratory at Stanford University in Palo Alto, CA. He specializes on the mechanisms of interaction of electric field and light with biological cells and tissues as well as the applications of these interactions to medicine and biology. He has contributed to the industrialization of key technologies like the PASCAL laser, the PEAK PlasmaBlade and the OCT-guided Femtosecond Laser for cataract surgery.

2019-09-25T10:13:31+02:00September 9th, 2019|Scientific and Medical Advisors|

Prof. Frank G. Holz

University Hospital Bonn (Germany)

Chairman of the department of ophthalmology, his main research interests include the pathogenesis, biomarkers and new therapies for macular and retinal diseases including age-related macular degeneration. His major clinical interest is medical and surgical retina. A scholar of the German National Academic Foundation, he trained at the University of Heidelberg, and the University of Chicago/Pritzker School of Medicine, and passed a fellowship at Moorfields Eye Hospital, London. He co-founded the Priority Program AMD of the German Research Council (DFG) and founded the GRADE Reading Center Bonn to perform digital image analysis in multi-centre clinical natural history and interventional trials. He is a Board Member of the German Ophthalmological Society (DOG), and EURETINA, Member of the Club Jules Gonin, the European Academy of Ophthalmology (EAO), the Macula Society, the Gass Club, Editor-in-Chief of Der Ophthalmologe, and serves a reviewer for many peer reviewed journals. He has received numerous awards and has published more than 400 articles in peer-reviewed journals and is editor of several books on retinal diseases.

2019-12-03T13:32:46+01:00September 9th, 2019|Scientific and Medical Advisors|

Prof. Jose Alain Sahel

Vision Institute (France) & UMPC Pittsburgh (USA)

Prof. Sahel is Professor, Université Pierre et Marie Curie, and Director of Institut de la Vision and Chairman of the Department of Ophthalmology at the Quinze-Vingts National Eye Hospital (Paris) and at the Rothschild Ophthalmology Foundation. He is also Professor at the Institute of Ophthalmology at the University College in London. He has been conducting pioneering research into the understanding of the pathological mechanisms involved in retinal cell degeneration. Prof. Sahel recently received awards from the US Foundation Fighting Blindness and the French “Académie des Sciences”, for his work on retinitis pigmentosa.

 

2019-09-09T14:41:26+02:00September 9th, 2019|Scientific and Medical Advisors|

Olivia Le Proux de la Rivière

Permanent Representative of BPI France Participations

Olivia Le Proux de la Rivière is investment associate with Large Venture Investment pole of Bpifrance. A graduate in applied mathematics (DEMIE) and a master in financial engeniering of Paris Dauphine University, she began her career in 2013 with the venture fund XAnge where she worked with the Munich team before joining ESADE Business School in 2014 to graduate in Finance. Following an internship with Citigroup in 2015, she is appointed associate in the M&A team in London specialized on TMT.

2019-09-09T14:24:37+02:00September 9th, 2019|Board of Directors|

Gérard Hascoët

Gérard Hascoët began his career in the medical technology business of Thomson CGR. As a serial entrepreneur, in 1985, he founded Technomed International, which is now a part of EDAP TMS, a Company dedicated to non-invasive medical treatment in urology. In 1993, he founded Sometec, a hemodynamic monitoring company acquired by Arrow International, and IMMI, a neurosurgical robotics company acquired by ISS. From 2008 to 2011, Gérard was CEO of SpineVision, a spinal implant company, and he continues to serve on the company’s Board of Directors. In 2009, he co-founded MD Start, a European incubator for medical technology companies, where he holds the position of Executive Chairman. Gérard is a Venture Partner of Sofinnova, one of the leading European healthcare venture capital firms. He is also Chairman of EOS Imaging, Chairman of CorWave, Director of the Board of LimFlow and  Ablacare. Gérard holds a degree in engineering from E.C.E Paris.

2019-10-11T11:43:22+02:00September 9th, 2019|Board of Directors|

Robert J.W. Ten Hoedt

Director

Mr. Ten Hoedt is currently the Executive Vice President & President, Europe, Middle East & Africa (EMEA) of Medtronic Plc. and a member of its Executive Committee. Mr. ten Hoedt has been with Medtronic since 1991 and has over 25 years of experience in the medical device industry. Leading up to this position, he has held several different leadership roles in Medtronic. He led the Cardio-Vascular business for Europe & Central Asia and the Gastro-Urology business on a global basis before which he ran the wholly-owned Medtronic subsidiary Company, Vitatron. Prior to Medtronic, he has held positions in medical technology companies such as Arjo Hospital Equipment and Polystan Benelux and also ran his own Distributor Company for several years. He is the Chairman of the Board of MedTech Europe, the Association representing the medical technology industry in Europe. He holds a degree in Commercial Economy from the H.E.A.O. and a Masters in Marketing from the NIMA Business School in the Netherlands.

2019-09-09T14:23:02+02:00September 9th, 2019|Board of Directors|

Marie Meynadier

Director

Marie Meynadier has over 25 years of experience int the high tech and medical device Industries. After receiving her doctorate, she joined Bellcore (Red Bank, NJ) and ATT Bell Labs (Murray Hill, NJ), where she conducted research on semiconductor devices. She then returned to France to lead the management of major national and international development programs in electronics, optics and microelectronics, which enabled the creation of several start-ups in these areas. Marie joined the medical field in 1999, taking leadership at the start-up Biospace lab, where she specialized in preclinical imaging and rapidly turned it into a profitable business. She has been exclusively dedicated to EOS imaging since 2008. Marie holds a degree in Electronic Engineering from Sup Telecom and a PhD (Doctorate) from the Ecole Normale Supérieure.

2019-09-09T14:22:00+02:00September 9th, 2019|Board of Directors|

Bernard Gilly

Chairman

Bernard Gilly has over 20 years of experience in the financial and pharmaceutical sectors, and as an entrepreneur. He was Vice-President R&D for 5 years at Pasteur Mérieux Connaught (now Sanofi Pasteur). Afterwards, he became the CEO of Transgene from 1992 to 2000, heading the Company’s listing and raising over $120 million. He later joined Sofinnova Partners in Paris (2000-2005). In 2005, he founded and became the CEO of Fovea Pharmaceuticals. After Fovea was acquired by Sanofi in 2009, he became Executive Vice President of the Ophthalmology Division of Sanofi. Lastly, he founded Pixium Vision in 2011.

2019-09-09T14:19:51+02:00September 9th, 2019|Board of Directors|

Ralf Hornig, PhD
Director of Clinical Affairs

Ralf Hornig, PhD
Director of Clinical Affairs
Dr. Ralf Hornig has more than 20 years of experience in Retinal Implant research and Artificial Vision. He received a degree in electrical engineering from the University of Hanover, Germany in 1995 and the PhD degree with highest honor in 2001 at the Technical University of Berlin, Germany. Between 1996 and 2001 his research activities included system tests, computer simulations, ASIC development as well as pre-clinical test for retina implants at the University of Bonn, Germany. From 2001 to 2012 he was member of the management team at Intelligent Medical Implants (IMI), where he was responsible for pre-clinical and clinical trials. He remains a scientific peer reviewer for international publications.

2020-04-09T17:43:51+02:00September 9th, 2019|Management|

Guillaume Buc
CTO

Guillaume Buc
Chief Technology Officer
Guillaume Buc has over 25 years’ experience in technology development. Before joining Pixium Vision, Mr. Buc held several management positions at GE Healthcare Europe. His latest role was CTO of the GEHC interventional cardiology department. He received an engineering degree from the French Ecole Polytechnique, in applied mathematics, and a degree from the Ecole Nationale Supérieure des Télécommunications / National Telecommunications School in Paris, in image processing and computer science.

2020-04-09T17:44:33+02:00September 9th, 2019|Management|